New Biotech Stocks To Watch – And More!
Companies involved in spectroscopy, bioelectronic medicine and telemedicine make up the three new biotech stocks to watch highlighted in today’s article, which also highlights new…
davidgoldstein
“Out Of Favor Healthcare Stocks Poised For Growth”: An Investing Theme For A Return To Normal
With the COVID-19 pandemic resulting in reduced doctor visits and delayed surgeries and procedures, many healthcare stocks have suffered this year. But as things begin…
How Will The Election Results Affect Tech, Growth, Biotech And Healthcare – And Who Will Outperform?
While President Trump still refuses to concede and control of the Senate is still technically to be determined, a Biden presidency come January 20th appears…
An ETF To Play The Biotech Sector Well Into 2021
For bullish biotech investors looking for a way to play the sector well into 2021, today’s article highlights an ETF to consider for that purpose,…
Biotech Stocks Of Every Kind For Investors Of Every Kind In 2021
From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks…
23 Stocks And ETFs That Stand To Benefit From A Biden Administration’s Changes (Or A Split Congress’ Lack Of Change)
From the country’s strategy for tackling COVID-19 to U.S.-China tensions to government regulations, some key changes can be expected under the coming Biden administration. At…
A High Risk/High Reward Way To Play The Shift To Biotech Solutions
When it comes to treating diseases, the author of today’s article notes “It seems that there is a shift away from treating symptoms with chemical…
A New Multi-Bagger Opportunity In The Electric Vehicle Space
For those who missed out on the massive rallies of Tesla and other electric vehicle companies, today’s article highlights another potential multi-bagger opportunity in the…
The Approval Of An Oregon Ballot Measure Could Make This Biotech Startup An Under-The-Radar Election Winner
Amid all the high drama surrounding last week’s elections, a smaller development could have big implications for one biotech startup. As today’s article explains, voters…
More Outperformance Ahead For These 2 “Class of 2018” Biotech Stocks?
The two biotech stocks highlighted in today’s article both made their public market debuts in 2018 – and both have performed very well for investors…